Sony Group Corp vs 10X Genomics Inc — how do they compare? Sony Group Corp trades at $21.11 (market cap $125.96B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Sony Group Corp is far larger — about 23× 10X Genomics Inc's market cap, and Sony Group Corp pays a 0.75% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| SONY | TXG | |
|---|---|---|
Market Cap | $125.96B | $5.48B |
Sector | Technology | Health |
52-Week High | $30.26 | $45.80 |
52-Week Low | $19.32 | $11.34 |
Enterprise Value | $122.45B | $5.02B |
Dividend Yield | 0.75% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →